Kuo‐Chien Tsao

No ORCID on file · 1 paper in corpus
article 2007
Journal of clinical laboratory analysis ·doi:10.1002/jcla.20168

As the best-known tumor marker for ovarian carcinoma, CA 125 has also been commonly used to monitor patients with common benign gynecologic diseases such as endometriosis and leiomyoma. Both of these benign tumors are known to be at risk of…